FDA approves removal of boxed-warning risk statements from three more estradiol patches

FDA approved removal of cardiovascular, breast cancer and dementia statements from boxed warnings on three more estradiol patches; also a STAT investigation of three-parent IVF tourism and an NLM pause on indexing Scientific Reports.